Picture of Agios Pharmaceuticals logo

AGIO — Agios Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Agios Pharma to discontinue sickle cell disease treatment development

Agios Pharma to discontinue sickle cell disease treatment development

- Agios Pharmaceuticals AGIO.O said on Tuesday it will stop development of its sickle cell disease treatment after results from a mid-stage trial did not establish a differentiated profile to support continued development.


(Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)

((Puyaan.Singh@thomsonreuters.com;))

Recent news on Agios Pharmaceuticals

See all news